Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

References for PMC Articles for PubMed (Select 23145809)

1.

Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia.

Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, Nagao Y, Hayashi J, Hashizume M, Maehara Y.

J Gastroenterol Hepatol. 2012 Feb;27(2):286-90. doi: 10.1111/j.1440-1746.2011.06870.x.

PMID:
21793908
2.

Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.

Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M.

Hum Mol Genet. 2011 Sep 1;20(17):3507-16. doi: 10.1093/hmg/ddr249. Epub 2011 Jun 9.

3.

Modulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis.

Hashimoto N, Shimoda S, Kawanaka H, Tsuneyama K, Uehara H, Akahoshi T, Kinjo N, Taketomi A, Shirabe K, Akashi K, Lleo A, Ansari AA, Gershwin ME, Maehara Y.

Clin Exp Immunol. 2011 Aug;165(2):243-50. doi: 10.1111/j.1365-2249.2011.04393.x. Epub 2011 May 25.

4.

Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function.

Hitomi Y, Cirulli ET, Fellay J, McHutchison JG, Thompson AJ, Gumbs CE, Shianna KV, Urban TJ, Goldstein DB.

Gastroenterology. 2011 Apr;140(4):1314-21. doi: 10.1053/j.gastro.2010.12.038. Epub 2011 Jan 1.

PMID:
21199653
5.

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR.

J Clin Invest. 2010 Dec;120(12):4546-57. doi: 10.1172/JCI43127. Epub 2010 Nov 15. Erratum in: J Clin Invest. 2011 Feb 1;121(2):821.

6.

Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C.

Honda M, Nakamura M, Tateno M, Sakai A, Shimakami T, Shirasaki T, Yamashita T, Arai K, Yamashita T, Sakai Y, Kaneko S.

J Hepatol. 2010 Nov;53(5):817-26. doi: 10.1016/j.jhep.2010.04.036. Epub 2010 Jul 15.

PMID:
20739080
7.

ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients.

Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Kubo M, Tsunoda T, Hayes CN, Kumada H, Nakamura Y, Chayama K.

Gastroenterology. 2010 Oct;139(4):1190-7. doi: 10.1053/j.gastro.2010.06.071. Epub 2010 Jul 14.

PMID:
20637204
8.

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Yamashita T, Nakamura M, Shirasaki T, Horimoto K, Tanaka Y, Tokunaga K, Mizokami M, Kaneko S; Hokuriku Liver Study Group.

Gastroenterology. 2010 Aug;139(2):499-509. doi: 10.1053/j.gastro.2010.04.049. Epub 2010 Apr 29.

PMID:
20434452
9.

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, Shianna KV, Little LD, Qiu P, Bertelsen AH, Watson M, Warner A, Muir AJ, Brass C, Albrecht J, Sulkowski M, McHutchison JG, Goldstein DB.

Nature. 2010 Mar 18;464(7287):405-8. doi: 10.1038/nature08825. Epub 2010 Feb 21.

PMID:
20173735
10.

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan.

Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y; Study Group for the Standardization of Treatment of Viral Hepatitis Including Cirrhosis, Ministry of Health, Labour and Welfare of Japan.

Hepatol Res. 2010 Jan;40(1):8-13. doi: 10.1111/j.1872-034X.2009.00634.x.

PMID:
20156296
11.

Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism.

Tomikawa M, Akahoshi T, Sugimachi K, Ikeda Y, Yoshida K, Tanabe Y, Kawanaka H, Takenaka K, Hashizume M, Maehara Y.

J Gastroenterol Hepatol. 2010 Feb;25(2):397-402. doi: 10.1111/j.1440-1746.2009.06031.x. Epub 2009 Nov 19.

PMID:
19929930
12.

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.

Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P.

Hepatology. 2010 Feb;51(2):388-97. doi: 10.1002/hep.23340.

PMID:
19918980
13.

Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.

Chen L, Borozan I, Sun J, Guindi M, Fischer S, Feld J, Anand N, Heathcote J, Edwards AM, McGilvray ID.

Gastroenterology. 2010 Mar;138(3):1123-33.e1-3. doi: 10.1053/j.gastro.2009.10.046. Epub 2009 Nov 6.

PMID:
19900446
14.

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M.

Nat Genet. 2009 Oct;41(10):1105-9. doi: 10.1038/ng.449. Epub 2009 Sep 13.

PMID:
19749757
15.

Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response.

Asahina Y, Izumi N, Hirayama I, Tanaka T, Sato M, Yasui Y, Komatsu N, Umeda N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Kurosaki M, Enomoto N, Tasaka M, Sakamoto N, Miyake S.

Gastroenterology. 2008 May;134(5):1396-405. doi: 10.1053/j.gastro.2008.02.019. Epub 2008 Feb 14.

PMID:
18471516
16.

Hepatocellular carcinoma: recent trends in Japan.

Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S17-26. Review.

PMID:
15508082
17.

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group.

Ann Intern Med. 2004 Mar 2;140(5):346-55.

PMID:
14996676
18.

Global burden of disease (GBD) for hepatitis C.

Global Burden Of Hepatitis C Working Group.

J Clin Pharmacol. 2004 Jan;44(1):20-9. Review.

PMID:
14681338
19.
20.

Laparoscopic splenectomy with an ultrasonic dissector.

Hashizume M, Sugimachi K, Ueno K.

N Engl J Med. 1992 Aug 6;327(6):438. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk